Current Liabilities
Accounts Payable
Biogen Accounts Payable decreased by 17.0% to $358.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.4%, from $391.50M to $358.50M. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows relatively stable performance with a -1.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
An increase can signal improved cash management or extended payment terms, while a decrease may indicate faster payments to suppliers or reduced purchasing activity.
Detailed definition
This represents the short-term obligations owed to suppliers and vendors for goods and services received on credit. It i...
Peer comparison
Standard current liability for all companies; comparable across industries based on days payable outstanding.
Metric ID:
accounts_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $375.30M | $427.90M | $589.20M | $398.70M | $434.80M | $383.20M | $491.50M | $491.20M | $445.40M | $440.10M | $403.30M | $387.00M | $354.50M | $422.70M | $424.20M | $391.50M | $408.40M | $413.10M | $432.00M | $358.50M |
| QoQ Change | — | +14.0% | +37.7% | -32.3% | +9.1% | -11.9% | +28.3% | -0.1% | -9.3% | -1.2% | -8.4% | -4.0% | -8.4% | +19.2% | +0.4% | -7.7% | +4.3% | +1.2% | +4.6% | -17.0% |
| YoY Change | — | — | — | — | +15.9% | -10.4% | -16.6% | +23.2% | +2.4% | +14.8% | -17.9% | -21.2% | -20.4% | -4.0% | +5.2% | +1.2% | +15.2% | -2.3% | +1.8% | -8.4% |
Range$354.50M – $589.20M
CAGR-1.0%
Avg YoY Growth-1.3%
Median YoY Growth-0.6%
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Biogen's accounts payable?
- Biogen (BIIB) reported accounts payable of $358.50M in Q1 2026.
- How has Biogen's accounts payable changed year-over-year?
- Biogen's accounts payable decreased by 8.4% year-over-year, from $391.50M to $358.50M.
- What is the long-term trend for Biogen's accounts payable?
- Over 5 years (2020 to 2025), Biogen's accounts payable has grown at a -1.0% compound annual growth rate (CAGR), from $454.90M to $432.00M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods or services.